Eventide Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-575,541	Closed	-$12.3M	–	269
2025 Q3	$12.3M	Sell	575,541 -152,896	-21%	-$3.62M	0.2%	121
2025 Q2	$15.7M	Sell	728,437 -124,408	-15%	-$2.31M	0.28%	107
2025 Q1	$14.2M	Hold	852,845	–	–	0.28%	105
2024 Q4	$15.6M	Buy	852,845 +275,345	+48%	+$4.44M	0.29%	109
2024 Q3	$8.88M	Buy	+577,500	New	+$9.63M	0.15%	125
2024 Q1	–	Sell	-809,391	Closed	-$25.3M	–	158
2023 Q4	$25.3M	Buy	+809,391	New	+$19.3M	0.41%	75
2018 Q3	–	Sell	-113,600	Closed	-$1.74M	–	146
2018 Q2	$1.74M	Hold	113,600	–	–	0.07%	118
2018 Q1	$2.55M	Sell	113,600 -221,100	-66%	-$6.12M	0.12%	103
2017 Q4	$10.1M	Hold	334,700	–	–	0.53%	61
2017 Q3	$12.6M	Hold	334,700	–	–	0.71%	53
2017 Q2	$9.34M	Hold	334,700	–	–	0.58%	51
2017 Q1	$11.5M	Hold	334,700	–	–	0.76%	47
2016 Q4	$9.65M	Hold	334,700	–	–	0.63%	51
2016 Q3	$10.6M	Hold	334,700	–	–	0.65%	49
2016 Q2	$10.9M	Hold	334,700	–	–	0.66%	52
2016 Q1	$9.36M	Hold	334,700	–	–	0.52%	56
2015 Q4	$11.9M	Buy	334,700 +8,000	+2%	+$282K	0.6%	55
2015 Q3	$10.8M	Buy	326,700 +55,600	+21%	+$2.31M	0.63%	49
2015 Q2	$11.4M	Hold	271,100	–	–	0.61%	54
2015 Q1	$8.84M	Sell	271,100 -152,100	-36%	-$5.23M	0.66%	57
2014 Q4	$13.4M	Hold	423,200	–	–	1.47%	24
2014 Q3	$10.5M	Hold	423,200	–	–	1.46%	27
2014 Q2	$9.56M	Buy	423,200 +229,700	+119%	+$4.8M	1.3%	33
2014 Q1	$4.71M	Buy	193,500 +18,100	+10%	+$458K	0.73%	55
2013 Q4	$4.38M	Buy	+175,400	New	+$4.14M	1.35%	40